Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Brilinta Recall Issued Due to Risk Samples May Contain Zurampic May 30, 2017 Russell Maas Add Your Comments Federal health officials have recalled a certain lot of the blood thinner Brilinta, after discovering that sample packages distributed to doctors may contain Zurampic, a drug used to treat high levels of uric acid in the blood, which may pose a variety of serious and potentially fatal risks to patients. The U.S. Food and Drug Administration (FDA) announced the Brilinta recall on May 26, indicating that at least one professional sample bottle with eight tablets of Brilinta 90mg also contained Zurampic 200mg tablets, which may cause patients requiring blood thinners to miss doses and put them at risk of bleeding events. In addition, side effects of Zurampic may also increase the risk of acute renal failure due to the unintentional use of the medication. Brilinta is a blood thinner used to reduce the risk of CV death, heart attacks and strokes in patients with acute coronary syndrome (ACS), or by those with history of heart attacks. Brilinta is also commonly used to reduce the rate of stent thrombosis in patients who have received stents for treatment of ACS. Do You Know about… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Failure to receive the prescribed dosage of Brilinta may result in serious and potentially fatal outcomes. According to the manufacturer, AstraZeneca, missed doses of Brilinta increase the risk of heart attacks and strokes, and those taking Brilinta for treatment of an implanted stent run an increased risk of getting a blood clot or having a serious heart attack. Zurampic, a drug also manufactured by AstraZeneca, is a prescription medication used in combination with a xanthine oxidase inhibitor in adults with gout to treat high levels of uric acid. Clinical trials and past warnings by the medical community have found evidence that using Zurampic without the combined use of a xanthine oxidase inhibitor may lead to adverse renal effects including acute renal failure. The FDA is urging medical professionals and patients that have received professional sample bottles of Brilinta 90mg tablets containing eight pills with bottles marked with the recalled Lot Number JB5047, to contact their healthcare provider immediately. Although the unintentional dosing of Zurampic with Brilinta may have serious side effects, the FDA is asking patients to not stop taking their prescriptions until they have contacted their healthcare providers, as the intentional stopping of Brilinta is nearly certain to result in serious adverse health consequences, and even death. Customers and healthcare professionals should be aware that Brilinta 90mg tablets are supplied as a round, biconvex, yellow, film-coated tablet imprinted with “90” above a “T” on one side of the pill, whereas Zurampic 200mg tablets are blue in color and elliptical/oval in shape and are imprinted with “LES200 on one side of the pill. The recalled Brilinta sample bottles were manufactured by AstraZeneca of Wilmington, Delaware where they were distributed to physicians in the United States between March 2017 and April 2017. According to the FDA, no other lots of AstraZeneca’s Brilinta are impacted by the recall. AstraZeneca has begun reaching out to customers across the nation with a recall letter and arrangements to return all of the recalled products. Patients with the recalled prescriptions are being asked to continue taking the medication as normal but to contact their healthcare provider immediately. Patients and physicians with additional questions or concerns regarding the recall may contact AstraZeneca Information Center at 1-800-236-9933. The FDA is asking for all adverse health events to be reported to the FDA’s MedWatch Adverse Event Reporting program immediately by completing and submitting the report online at www.fda.gov/medwatch/report.htm or by calling 1-800-332-1088. Brilinta, also known as ticagrelor, was developed by AstraZeneca and approved by the FDA in July 2011, carrying a black box warning for bleeding risks, similar to that of other blood thinners. However, in September 2016, a study by European researchers published in the medical journal JAMA Cardiology, examined the side effects of Brilinta among patients with acute coronary syndromes, comparing use of the blood thinner with or without aspirin before undergoing coronary artery bypass grafting. The findings suggest that taking Brilinta up to, or at least two days before, such surgeries increases the risk of severe bleeding events by nearly 20%. After reviewing nearly 800 Brilinta users across 15 cardiac surgery facilities in Europe, researchers found that preoperative use of Brilinta up to the time of surgery or discontinuing it less than two days before surgery was associated with a 22.7% higher risk of platelet transfusion and an 18.2% increased risk of severe bleeding events when compared to patients given aspirin alone. More Lawsuit Stories Depo-Provera Shots Triple Brain Tumor Risks Compared to Birth Control Pill: Study July 11, 2025 Cancer-Causing PFAS Water Contamination in 98% of Tested Sites in U.S.: Report July 11, 2025 Lawsuit Alleges Risperdal, Zyprexa Caused Breast Cancer Diagnosis July 11, 2025 1 Comments Marilyn June 5, 2017 I have bottles of the medication in question. Is the incorrect medication easily identified? Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermNameThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Depo-Provera Shots Triple Brain Tumor Risks Compared to Birth Control Pill: Study (Posted: yesterday) Canadian researchers say receiving Depo-Provera injections for more than a year triples the risk of brain tumors compared to women who take birth control pills. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Lawsuit Pre-Settlement Funding and Loans Must Be Disclosed Under Court Order (07/09/2025)Depo-Provera Wrongful Death Lawsuit Blames Injections for Fatal Brain Tumor (07/02/2025)Lawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks (06/20/2025) Uber Faces Lawsuit Indicating Driver Raped Passenger After Using Wife’s Account (Posted: 2 days ago) A lawsuit filed by a Florida woman says she was raped after an Uber driver’s husband showed up behind the wheel. MORE ABOUT: UBER SEXUAL ASSAULT LAWSUITUber Driver Background Check Materials Must Be Produced in Sexual Assault Lawsuits: Court (06/17/2025)MDL Judge Updated on Uber Driver Sex Assault Lawsuit Status as Claims Top 2,800 (06/06/2025)Uber Seeks To Transfer MDL Sexual Assault Lawsuits to Districts Where Attacks Occurred for Trial (05/23/2025) Depo-Provera Lawsuit Pre-Settlement Funding and Loans Must Be Disclosed Under Court Order (Posted: 3 days ago) A U.S. District Judge has ordered women involved in Depo-Provera lawsuits to inform him of any third-party pre-settlement loans they take out, as predatory interest rates may force them to reject settlement offers. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Shots Triple Brain Tumor Risks Compared to Birth Control Pill: Study (07/11/2025)Depo-Provera Wrongful Death Lawsuit Blames Injections for Fatal Brain Tumor (07/02/2025)Lawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks (06/20/2025)
Depo-Provera Shots Triple Brain Tumor Risks Compared to Birth Control Pill: Study (Posted: yesterday) Canadian researchers say receiving Depo-Provera injections for more than a year triples the risk of brain tumors compared to women who take birth control pills. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Lawsuit Pre-Settlement Funding and Loans Must Be Disclosed Under Court Order (07/09/2025)Depo-Provera Wrongful Death Lawsuit Blames Injections for Fatal Brain Tumor (07/02/2025)Lawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks (06/20/2025)
Uber Faces Lawsuit Indicating Driver Raped Passenger After Using Wife’s Account (Posted: 2 days ago) A lawsuit filed by a Florida woman says she was raped after an Uber driver’s husband showed up behind the wheel. MORE ABOUT: UBER SEXUAL ASSAULT LAWSUITUber Driver Background Check Materials Must Be Produced in Sexual Assault Lawsuits: Court (06/17/2025)MDL Judge Updated on Uber Driver Sex Assault Lawsuit Status as Claims Top 2,800 (06/06/2025)Uber Seeks To Transfer MDL Sexual Assault Lawsuits to Districts Where Attacks Occurred for Trial (05/23/2025)
Depo-Provera Lawsuit Pre-Settlement Funding and Loans Must Be Disclosed Under Court Order (Posted: 3 days ago) A U.S. District Judge has ordered women involved in Depo-Provera lawsuits to inform him of any third-party pre-settlement loans they take out, as predatory interest rates may force them to reject settlement offers. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Shots Triple Brain Tumor Risks Compared to Birth Control Pill: Study (07/11/2025)Depo-Provera Wrongful Death Lawsuit Blames Injections for Fatal Brain Tumor (07/02/2025)Lawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks (06/20/2025)